GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Healios KK (TSE:4593) » Definitions » Common Stock

Healios KK (TSE:4593) Common Stock : 円1,359.0 Mil (As of Jun. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Healios KK Common Stock?

Healios KK's quarterly common stock increased from Dec. 2023 (円1,678.0 Mil) to Mar. 2024 (円2,800.0 Mil) but then declined from Mar. 2024 (円2,800.0 Mil) to Jun. 2024 (円1,359.0 Mil).

Healios KK's annual common stock declined from Dec. 2021 (円6,179.0 Mil) to Dec. 2022 (円4,566.0 Mil) and declined from Dec. 2022 (円4,566.0 Mil) to Dec. 2023 (円1,678.0 Mil).


Healios KK Common Stock Historical Data

The historical data trend for Healios KK's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Healios KK Common Stock Chart

Healios KK Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12,822.00 4,991.00 6,179.00 4,566.00 1,678.00

Healios KK Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 176.00 1,678.00 1,678.00 2,800.00 1,359.00

Healios KK Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


Healios KK Business Description

Traded in Other Exchanges
Address
World Trade Center Bldg. 15th Floor, 2-4-1 Hamamatsucho, Minato-ku, Tokyo, JPN, 105-6115
Healios KK is involved in development and sales of opthalmological surgery adjuvants and research, development and manufacture of cell therapy products and regenerative medicine products. The company is developing treatments for age-related macular degeneration and organ anlage transplantation therapy.

Healios KK Headlines

No Headlines